Skip to content
Accelerator / StudioPuts its own capital into companiesActive · deal in last 18 monthsLAST VERIFIED Oct 2026 · 8 SOURCES

Cube Labs

Also known as Cube Labs S.p.A.

Rome-based healthcare-technology venture builder listed on Euronext Growth Milan (PRO segment) since March 2023; founds and holds stakes in academic life-science spin-offs.

HEADQUARTERS
Rome, Italy
FOUNDED
—
AUM
—
OUTSIDE CAPITAL
—
TEAM LISTED
6 people

Focus

STAGES
Pre-SeedSeed
SECTORS
Biotech & Life SciencesHealthTechArtificial Intelligence
GEOGRAPHY
Italy

Overview

Cube Labs S.p.A. is an Italian venture builder in healthcare technology that creates companies from academic R&D and supports them through incubation, acceleration and growth/exit. It listed on the professional segment of Euronext Growth Milan in March 2023. Founder and CEO Filippo Surace holds 60.50% of the capital (51.56% through Keltinvest S.r.l.); Algebris Investments holds 7.69%. Focus areas are pharmaceuticals, biotech, nutraceuticals, R&D tech/AI and medtech.

Investment thesis

Creates startups from promising academic R&D in life sciences (pharmaceuticals, biotech, nutraceuticals, R&D tech/AI, medtech) and takes them to licensing, M&A or IPO.

PORTFOLIO (4)

  • DeepCyt
    HealthTech · since 2026
  • Hiperforming Research
    Artificial Intelligence
  • FluoDetect
    Deep Tech · since 2024
  • Serescentia (wholly owned subsidiary)
    HealthTech · since 2026

People

  • Filippo Surace
    Founder & Chief Executive Officer · source
  • Renato Del Grosso
    Co-Founder & Chief Strategy Officer · source
  • Massimo Fiocchi
    Co-Founder & Chief Financial Officer · source
  • Christopher Hentschel
    Chief Scientific Officer · source
  • Neil Thomas
    Chief Business Officer · source
  • Ennio Tasciotti
    Scientific Director of Technology Transfer · source

Links

Frequently asked questions

Cube Labs is a accelerator based in Rome, Italy.

Yes. Cube Labs invests its own capital in private companies.

Cube Labs invests at Pre-Seed and Seed stages in Biotech & Life Sciences, HealthTech and Artificial Intelligence.

Key people at Cube Labs include Filippo Surace (Founder & Chief Executive Officer), Renato Del Grosso (Co-Founder & Chief Strategy Officer), Massimo Fiocchi (Co-Founder & Chief Financial Officer) and Christopher Hentschel (Chief Scientific Officer).

Cube Labs's investments include DeepCyt, Hiperforming Research, FluoDetect and Serescentia (wholly owned subsidiary).

The most recent publicly reported investment by Cube Labs is DeepCyt (Minority stake (1.1% of capital increase)), announced in Oct 2026.